Ozempic stories

Sep 9, 2026

Semaglutide linked to 40% reduction in asthma attacks in large real-world study

A large observational study found semaglutide (Ozempic/Wegovy) was associated with nearly 40% fewer asthma attacks and about 20% fewer COPD flare-ups compared to other treatments.

Sep 9, 20262 sources

Jul 14, 2026

Semaglutide may slow biological aging in adults with HIV

Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging beyond its metabolic effects.

Jul 14, 20261 source

Jul 9, 2026

Dr. Reddy's Delays Generic Ozempic Launch Due to Ingredient Quality Issue

Indian drugmaker Dr. Reddy's Laboratories announced it is delaying commercial production of its generic semaglutide (Ozempic) after discovering an unspecified issue with the active pharmaceutical ingredient in some batches. Shares fell as much as 6.5%.

Jul 9, 20262 sources

May 3, 2026

Stopping and Restarting GLP-1 Weight Loss Drugs May Reduce Their Effectiveness

Preclinical study from University of Pennsylvania researchers finds that inconsistent use of GLP-1 medications like Ozempic and Wegovy may significantly lessen their effectiveness for weight loss.

May 3, 20261 source

GLP-1 Drugs Taken Around Pregnancy Show No Increased Risk of Birth Defects in New Study

University of St Andrews study published in American Journal of Obstetrics suggests weight-loss drugs like Ozempic taken around pregnancy do not raise the risk of major birth defects.

May 3, 20261 source

Apr 13, 2026

Genetic Variants Explain Why GLP-1 Drugs Like Ozempic Don't Work for 10% of Patients

New research reveals that approximately 10% of people carry specific genetic variants that make popular diabetes and weight-loss drugs like Ozempic and Wegovy significantly less effective, providing the first genetic explanation for variable drug response.

Apr 13, 20261 source